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Short Communication
Whitehead’s varnish nasal pack
M LIM, S LEW-GOR, G SANDHU, D HOWARD, V J LUND
Abstract
Whitehead’s varnish is a little known but excellent nasal packing agent. We review available literature on the
historical aspects and clinical use of Whitehead’s varnish. Our personal experience with Whitehead’s varnish
is described, and we strongly recommend its use.
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Introduction
The ideal material for emergency nasal or paranasal sinus
cavity packing for epistaxis, or in the post-surgical
context, should fulfil several criteria. It should aid
healing, be analgesic, and have haemostatic and antiseptic
properties. It should also be cheap, with few undesirable
side effects. Various packing material have been used,
including Rapid Rhinow Riemann, Telfaw and Merogelw
(hyaluronic acid pack). When bleeding is more likely (e.g.
excision of a sinonasal tumour), other packing agents
such as Merocelw and bismuth subnitrate–iodoform paste
have been employed.
We describe the clinical use and explore the historical
background of Whitehead’s varnish pack – forgotten in
many parts of the country but, in our experience, a packing
agent of tremendous value.
The life of Walter Whitehead
Walter Whitehead was born at Haslam Hey, Bury, on 12
October 1840. He came from an illustrious family of inven-
tors, including Robert Kay (his maternal great great grand-
father and inventor of the drop-box used in weaving), John
Kay (his maternal great great great grandfather and inven-
tor of the fly-shuttle) and Robert Whitehead (his uncle and
inventor of the torpedo).
Whitehead attended Making Place School at Ripponden,
Halifax, where he did well. At the age of 16 years, he entered
his father’s bleaching business. However, he often found
more pleasure in the company of medical students at the
Manchester Royal Infirmary, and soon enrolled into the
Chatham Street School of Medicine, Manchester. He quali-
fied in 1864, and in 1866 became a Fellow of the Royal
College of Surgeons of Edinburgh. In 1873, he was
appointed honorary assistant surgeon to the Manchester
Royal Infirmary, and became honorary surgeon there in
1879. He served in the same hospital until 1900, when he
retired at the age of 60. He died 13 years later (19 August
1913).
In 1894, Walter Whitehead was appointed professor of
clinical surgery in Owen’s College, Victoria University,
Manchester. Although he certainly commanded the
respect of his pupils, it is said that he did very little
teaching. However, when he did conduct bedside teaching,
his ward classes were always well attended. In 1902, he was
elected president of the British Medical Association, which
in the same year held its annual meeting in Manchester.
The success of this meeting was largely attributed to White-
head’s organisational skills and social spirit.
During his career, Whitehead published nearly 50
articles. In 1870, he established, together with a friend,
the publication Manchester Medical and Surgical Reports.
One of his most important early papers (on colitis) was
published in this journal in 1870.
Whitehead was a pioneer of several surgical procedures.
The three most important of these include a modification
of a method for tracheostomy, removal of haemorrhoids
and excision of the tongue. In modifying the method for
tracheostomy, he described the use of a raspatory to get
down to the trachea following incision through skin and
fascia. He felt that this method was easier, caused less
haemorrhage and required fewer instruments.1 With
regards to haemorrhoid excision, he wrote the original
paper in 1882 describing in great detail his surgical method-
ology.2 In 1887, he published a further paper reporting a
series of 300 cases, in which he proudly professed that ‘to
the best of my knowledge, every patient has been comple-
tely and permanently cured’.3
In 1891, Whitehead published a paper, in both the
British Medical Journal and the Lancet,4,5 reporting 100
cases of excision of the entire tongue. It was in this paper
that he described what we now know as Whitehead’s
ointment.
Whitehead’s varnish
History
In his original 1891 article on excision of the tongue,
Whitehead carefully described the treatment of the floor
of the mouth after the tongue had been removed.4,5 First,
he used a mercurial solution of biniodide to swab the raw
surface. After this had dried, he reported ‘finally painting
the surface with the iodoform styptic varnish which I intro-
duced in 1881’. He goes on to describe the preparation of
this iodoform varnish, which consists of Friar’s balsam
without its original spirit, a saturated ethereal solution of
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iodoform and, mixing with the ether, one volume in 10 of
turpentine. Whitehead wrote that this preparation had
antiseptic and anaesthetic properties, the anaesthetic prop-
erties such that ‘it enables the patient to take food in the
ordinary manner almost immediately after the operation’.
The addition of turpentine also had a ‘very marked influ-
ence in promptly checking the capillary oozing’.
Chemical properties
Whitehead’s varnish is also known as Whitehead’s oint-
ment, iodoform varnish and compound iodoform paint
(Figure 1). The active ingredient in Whitehead’s varnish
is iodoform, or tri-iodomethane. This consists of a central
carbon atom with one hydrogen and three iodine atoms
(CHI3). Iodoform exists as shining yellow crystals or
powder at room temperature and is practically insoluble
in water. Thus, it is prepared in topical form as ether, in
which it is soluble one in eight.6 Other excipients include
benzoin (British preparation), storax (British preparation)
and tolu balsam (British preparation), all constituents of
Friar’s balsam (tincture of benzoin).
Pharmacodynamic and pharmocokinetic properties
Iodoform releases elemental iodine when applied to
tissues. Systemic absorption of iodine can occur on pro-
longed or extensive application to open wounds. This
may cause adverse effects, including sensitivity reactions,
systemic toxicity and aggravation of thyroid disorders. As
a precaution, not more than 2 g (or 20 ml of Whitehead’s
ointment) should be administered to a wound.
Clinical use
Whitehead’s varnish forms a protective ‘skin’ covering for
wounds and thus may be directly applied to wounds as a
dressing. Due to its adhesive properties, Whitehead’s
varnish will also help in holding gauze dressings in
position. The iodoform released has a marked anaesthetic
action when applied to mucosal membranes.6
In a randomised, controlled trial on skin autograft donor
site management, subjects were randomised into two
groups: one group receiving Jelonetw to the donor site
and the other group being dressed with both Jelonet and
Whitehead’s varnish.7 Whitehead’s varnish significantly
reduced donor site pain compared with the standard dres-
sing (p ¼ 0.0006). Although overall healing time was not
statistically different in the two groups, larger donor sites
treated with Jelonet and Whitehead’s varnish healed
more quickly than those treated with the standard dressing
alone. Interestingly, because of its anaesthetic action, it has
been reported that Whitehead’s varnish may affect peri-
pheral nerve function and may be responsible for post-
operative sensory disturbances,8 although we have had no
cases with this problem in our experience.
In our practice, we use 2.5 cm wide ribbon gauze soaked
in Whitehead’s varnish to pack nasal cavities and neck
wounds after surgery (Figure 2). A practical point to note
is that, once soaked in Whitehead’s varnish, the ribbon
gauze must be packed immediately, as the ether in the oint-
ment evaporates quite quickly. In addition, the presence of
ether in the varnish means that diathermy should not be
used after the pack has been inserted.
Following excision of sinonasal tumours, we routinely
pack patients’ postsurgical nasal or paranasal cavities to
secure haemostasis. The pack is left in situ for five to
seven days on average, but larger cavities (e.g. after
FIG. 1
Whitehead’s varnish
FIG. 2
2.5 cm ribbon gauze soaked in whitehead’s varnish
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craniofacial resection) may be packed for 10 days.
Although Whitehead’s varnish has an antiseptic effect,
antibiotics are prescribed for the duration of the pack, as
the ribbon gauze still represents a foreign body in the
nasal cavity. Removal of the pack (Figure 3) should be per-
formed under a general anaesthetic as it can be quite
painful.
We reviewed all our cases receiving Whitehead’s varnish
pack insertion over the previous four and a half years.
There were 421 cases in total over this period. No adverse
effects were reported in any of the cases.
The same soaked ribbon gauze can be used as emergency
nasal packing in patients with epistaxis. In contrast to the
commonly used bismuth nitrate–iodoform paste, which
also contains iodoform, Whitehead’s varnish on ribbon
gauze has the important advantage of being minimally
irritative to the mucosal lining of the nose. Additionally,
iodoform toxicity has been reported following use of
bismuth nitrate–iodoform paste packing in large cavities,
and it has been suggested that Whitehead’s varnish is a
safer alternative in this instance.9
The compressive effect of a Whitehead’s varnish pack
not only secures haemostasis but may also be used to
apply pressure on a skin/fascia graft used in cerebrospinal
fluid (CSF) leak repair or septodermatoplasty. In these
cases, we first glue the graft into place with bioglue and
then interpose a layer of Gelfoamw between the graft and
the Whitehead’s pack to prevent adherence between the
two.
Conclusion
The use of Whitehead’s varnish in nasal or paranasal cavity
packing is safe and effective. It is especially useful for
packing following excision of sinonasal tumours, which
tend to bleed. It may also be employed in cases in which
a skin or fascia graft is used (e.g. septodermatoplasty or
CSF leak repair), to aid in holding the graft in place
whilst concomitantly securing haemostasis. The advantage
of the Whitehead’s pack in these instances is that it pro-
vides firm compression without chemically damaging the
nasal mucosa. It further provides an anaesthetic effect
and may aid in the wound healing process. It is safe and
relatively inexpensive. We would strongly recommend its
use in these instances. Indeed, it is pack worthy of the
name by which it has been called.
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